Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ponzoni

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Lymphokine Research|January 1, 1988
A human acute leukemia-derived T-cell line produces two inhibitor factors which suppress lymphocyte proliferation: characterization and purification of the moleculesP G Montaldo, M Lanciotti, E Castagnola, et al.
Cancer Research|February 15, 1995
Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiationM Ponzoni, P Bocca, V Chiesa, et al.
Cancer Letters|July 26, 2003
Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapseL Raffaghello, D Marimpietri, G Pagnan, et al.
Life Sciences|March 3, 2001
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastomaD Ribatti, G Surico, A Vacca, et al.
Pediatric Research|January 1, 1990
A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-mycP Cornaglia-Ferraris, M Ponzoni, P Montaldo, et al.
International Journal of Cancer|April 3, 1999
N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell deathP G Montaldo, G Pagnan, F Pastorino, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2022
EAHP 2020 workshop proceedings, pediatric myeloid neoplasmsR J Leguit, A Orazi, N Kucine, et al.
Cell Death and Differentiation|February 23, 2002
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patientsI Casciano, K Mazzocco, L Boni, et al.
Journal of the National Cancer Institute|February 3, 2000
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effectsG Pagnan, D D Stuart, F Pastorino, et al.
Cancer Letters|July 26, 2003
Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastomaL Raffaghello, G Pagnan, F Pastorino, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Lymphokine Research|January 1, 1988
A human acute leukemia-derived T-cell line produces two inhibitor factors which suppress lymphocyte proliferation: characterization and purification of the moleculesP G Montaldo, M Lanciotti, E Castagnola, et al.
Cancer Research|February 15, 1995
Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiationM Ponzoni, P Bocca, V Chiesa, et al.
Cancer Letters|July 26, 2003
Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapseL Raffaghello, D Marimpietri, G Pagnan, et al.
Life Sciences|March 3, 2001
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastomaD Ribatti, G Surico, A Vacca, et al.
Pediatric Research|January 1, 1990
A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-mycP Cornaglia-Ferraris, M Ponzoni, P Montaldo, et al.
International Journal of Cancer|April 3, 1999
N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell deathP G Montaldo, G Pagnan, F Pastorino, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2022
EAHP 2020 workshop proceedings, pediatric myeloid neoplasmsR J Leguit, A Orazi, N Kucine, et al.
Cell Death and Differentiation|February 23, 2002
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patientsI Casciano, K Mazzocco, L Boni, et al.
Journal of the National Cancer Institute|February 3, 2000
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effectsG Pagnan, D D Stuart, F Pastorino, et al.
Cancer Letters|July 26, 2003
Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastomaL Raffaghello, G Pagnan, F Pastorino, et al.
Pageof 12